Clinical Trial Update: Adherence to Hydroxyurea in Children With Sickle Cell Anemia [NA]

View source ↗

Summary

A completed clinical trial from Duke University evaluated adherence to hydroxyurea therapy in children with sickle cell disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• DROXIA (HYDROXYUREA)
• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Duke University | Conditions: Sickle Cell Anemia | NA | Status: COMPLETED